Solana price prediction leads weekly stablecoin inflows and DEX revenue while SOL trades near oversold support, eyeing a rebound toward the $130 resistance zoneSolana price prediction leads weekly stablecoin inflows and DEX revenue while SOL trades near oversold support, eyeing a rebound toward the $130 resistance zone

Solana price prediction bulls eye rebound as $1.3b stablecoin inflows hit key support

2 min read

Solana price prediction leads weekly stablecoin inflows and DEX revenue while SOL trades near oversold support, eyeing a rebound toward the $130 resistance zone.

Summary
  • Solana price prediction captured about $1.3b in weekly net stablecoin inflows, far ahead of rival chains.
  • SOL trades near technical support with oversold signals but still bearish momentum.
  • Ethereum saw sizable stablecoin outflows as Solana led DEX revenue and volume among major networks.

Solana (SOL) price prediction as bulls recorded the largest weekly stablecoin inflows among major blockchain networks, according to data from Artemis, as the cryptocurrency’s price traded near technical support levels.

The blockchain registered approximately $1.3 billion in net stablecoin inflows over the seven-day period, representing the highest positive net change among competing networks, according to the data. Solana was the only chain to record such substantial inflows during the period measured.

SOL, the network’s native token, traded near support levels following a daily decline and a larger weekly drop. The asset’s 24-hour trading volume increased significantly during the period, according to market data.

Institutional investment in Solana-based exchange-traded funds remained limited. U.S. spot SOL ETFs reported minimal inflows last week, marking the lowest levels in recent records, according to fund flow data.

Ethereum, by contrast, registered substantial stablecoin outflows during the same period, topping outflow rankings among major blockchain networks, the Artemis data showed. Other networks including Ripple, Polygon PoS, Aptos, and Arbitrum recorded mixed results but remained significantly behind Solana in stablecoin activity.

Solana also led in decentralized exchange revenue and volume during the period, according to blockchain analytics data. The network’s performance in short-term DEX revenue outpaced other layer one and layer two blockchain platforms.

The broader cryptocurrency market declined recently amid regulatory concerns and liquidations of leveraged positions, according to market analysts. Major digital assets remained below recent price highs.

Technical indicators showed SOL trading near oversold territory with signs of potential recovery, though momentum measures remained bearish, according to chart analysis. The cryptocurrency traded within a defined range between support and resistance levels.

Analysts noted that a sustained move above resistance levels would be required to signal a renewed upward trend, while failure to hold support could trigger further downside movement. The asset targets a rebound toward the $130 resistance level, according to technical projections.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29